Medical Devices Law & Industry Report provides complete in-depth, interdisciplinary news coverage of all major developments in the rapidly changing medical...
June 16 — Medicare payments for clinical lab tests are poised for an update under a long-delayed final rule that the White House cleared June 15.
The move indicates the rule on Medicare payments for diagnostic labs test from the Centers for Medicare & Medicaid Services could be released soon. The White House Office and Management and Budget reviews all major proposed and final regulations before release.
The OMB started reviewing the final rule April 21, months behind schedule (10 MELR 09, 4/27/16).
A proposed version of the rule (80 Fed. Reg. 59,386), published in October 2015, outlined plans to use data collected from clinical labs about how much they are paid by private insurers for tests to determine the new Medicare payment rates. Lab payments under the new system would start Jan. 1, 2017, the proposed rule said.
Medicare pays about $8 billion per year for the approximately 1,300 lab tests covered by the fee schedule. The proposed changes could result in $360 million less in Part B payments in fiscal year 2017 for Medicare-covered clinical lab tests.
The final rule has long been anticipated by the lab industry. In its November 2015 comments (docket CMS-1621-P) on the proposal, Quest Diagnostics, a large test company, urged the CMS to delay implementing the new system until 2018 (09 MELR 24, 12/9/15). Congress had mandated that the final rule be released by June 30, 2015, according to information about the regulation posted on the OMB's reginfo.gov site.
The rule would implement Section 216 of the Protecting Access to Medicare Act of 2014, or PAMA.
To contact the reporter on this story: Michael D. Williamson in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Brian Broderick at email@example.com
The proposed rule is at https://www.gpo.gov/fdsys/pkg/FR-2015-10-01/pdf/2015-24770.pdf.
The OMB's listing for the rule is at http://www.reginfo.gov/public/do/eoDetails?rrid=126245.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)